The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The prognostic impact of KRAS mutation in colorectal cancer patients: A meta-analysis of phase III clinical trials.
Clarinda Wei Ling Chua
No relevant relationships to disclose
Dawn QQ Chong
No relevant relationships to disclose
Ravindran Kanesvaran
No relevant relationships to disclose
Wai Meng David Tai
No relevant relationships to disclose
Chee Kian Tham
No relevant relationships to disclose
Patrick Tan
No relevant relationships to disclose
Arul Earnest
No relevant relationships to disclose
Iain B. Tan
No relevant relationships to disclose